General Information of the Compound
Compound ID
CP0006265
Compound Name
(3R)-N-(6-imidazol-1-ylpyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine
    Show/Hide
Synonyms
BMS-933043
    Show/Hide
Structure
Formula
C16H19N7O
Molecular Weight
325.376
Canonical SMILES
C1N=C(Nc2cc(ncn2)-n2ccnc2)O[C@]11CN2CCC1CC2
    Show/Hide
InChI
InChI=1S/C16H19N7O/c1-4-22-5-2-12(1)16(9-22)8-18-15(24-16)21-13-7-14(20-10-19-13)23-6-3-17-11-23/h3,6-7,10-12H,1-2,4-5,8-9H2,(H,18,19,20,21)/t16-/m0/s1
    Show/Hide
InChIKey
RLXBHTUZCPORKT-INIZCTEOSA-N
Physicochemical Property
logP
0.9248
Rotatable Bonds
2
Heavy Atom Count
24
Polar Areas
80.46
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 59286554
ChEMBL ID
CHEMBL4084621
Clinical Information about the Compound
Drug 1 ( BMS-933043 )
Drug Name BMS-933043
Company Bristol-Myers Squibb
Indication
Psychiatric disorder
Phase 1
Target(s)
Neuronal acetylcholine receptor alpha-7 (CHRNA7)
Modulator